Design and synthesis of novel thiazolidine-2,4-diones as hypoglycemic agents - ScienceDirect
PDF) An overview on medicinal perspective of thiazolidine-2,4-dione: A remarkable scaffold in the treatment of type 2 diabetes
Molecules | Free Full-Text | Functionalized 1,3-Thiazolidin-4-Ones from 2-Oxo-Acenaphthoquinylidene- and [2.2]Paracyclophanylidene-Thiosemicarbazones
Discovery of novel 1,3,5-triazine-thiazolidine-2,4-diones as dipeptidyl peptidase-4 inhibitors with antibacterial activity targeting the S1 pocket for ... - RSC Advances (RSC Publishing) DOI:10.1039/C4RA16903D
IJMS | Free Full-Text | The Bioactivity of Thiazolidin-4-Ones: A Short Review of the Most Recent Studies
Thiazole-based and thiazolidine-based protein tyrosine phosphatase 1B inhibitors as potential anti-diabetes agents | SpringerLink
Insulinsensitizer beim Typ-2-Diabetes: Pioglitazon wirkt auch kardioprotektiv
An overview on medicinal perspective of thiazolidine-2,4-dione: A remarkable scaffold in the treatment of type 2 diabetes - ScienceDirect
Mechanism for the synthesis of 1,3-thiazolidin-4-ones using... | Download Scientific Diagram
2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P1 Receptor Agonists | Journal of Medicinal Chemistry
An overview on medicinal perspective of thiazolidine-2,4-dione: A remarkable scaffold in the treatment of type 2 diabetes - ScienceDirect
Verwendung von Thiazolidin- oder Pyrrolidinderivaten von Aminosäuren als antihyperglykämische Mittel - European Patent Office
Design and synthesis of novel thiazolidine-2,4-diones as hypoglycemic agents – topic of research paper in Chemical sciences. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Pioglitazon. Molekulares Modell des Medikament Pioglitazon (C19. H20. N2. O3. (S), verwendet für die Behandlung von Diabetes Mellitus Typ 2. Es ist ein Thiazolidindionen Medikament, das senkt den Blutzuckerspiegel (blutzuckersenkende Wirkung). Atome
An overview on medicinal perspective of thiazolidine-2,4-dione: A remarkable scaffold in the treatment of type 2 diabetes - ScienceDirect
Rosiglitazon. Molekulares Modell des Medikament Rosiglitazon (C18. H19. N3. O3. (S), ein Thiazolidindionen Klasse Anti-Diabetes Medikament als ein Insulin sensibilisierend. Atome als Kugeln dargestellt werden und sind farblich gekennzeichnet ...
An overview on medicinal perspective of thiazolidine-2,4-dione: A remarkable scaffold in the treatment of type 2 diabetes - ScienceDirect
Thiazole-based and thiazolidine-based protein tyrosine phosphatase 1B inhibitors as potential anti-diabetes agents | SpringerLink
Chemical structures of thiazolyl-thiazolidine-2,4-dione compounds. | Download Scientific Diagram
Pioglitazon. Molekulares Modell des Medikament Pioglitazon (C19. H20. N2. O3. (S), verwendet für die Behandlung von Diabetes Mellitus Typ 2. Es ist ein Thiazolidindionen Medikament, das senkt den Blutzuckerspiegel (blutzuckersenkende Wirkung). Atome
An overview on medicinal perspective of thiazolidine-2,4-dione: A remarkable scaffold in the treatment of type 2 diabetes - ScienceDirect
Processes | Free Full-Text | A New Symmetrical Thiazolidinedione Derivative: In Silico Design, Synthesis, and In Vivo Evaluation on a Streptozotocin-Induced Rat Model of Diabetes
Insulin mit eingebautem Zuckersensor | PZ – Pharmazeutische Zeitung